The beneficial role of left ventricular assist device destination therapy in the reversal of contraindications to cardiac transplantation

被引：9

作者：

Choong, CK

Pasque, MK

Shelton, K

Kehoe-Huck, B

Ewald, GA

Horstmanshof, D

Moazami, N

机构：

[1] Washington Univ, Sch Med, Div Cardiothorac Surg, St Louis, MO 63110 USA

[2] Washington Univ, Sch Med, Div Cardiol, St Louis, MO 63110 USA

来源：

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 2005年 / 130卷 / 03期

关键词：

D O I：

10.1016/j.jtcvs.2005.02.014

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：879 / 880

页数：2

共 4 条

[1] The Registry of the International Society for Heart and Lung Transplantation: Eighteenth official report-2001 [J].

Hosenpud, JD ;

Bennett, LE ;

Keck, BM ;

Boucek, MM ;

Novick, RJ .

JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (08) :805-815

[2] Destination therapy in late-stage heart failure [J].

Mehra, MR ;

Uber, PA ;

Uber, WE ;

Ventura, HO .

CORONARY ARTERY DISEASE, 2004, 15 (02) :87-90

[3] Long-term use of a left ventricular assist device for end-stage heart failure [J].

Rose, EA ;

Gelijns, AC ;

Moskowitz, AJ ;

Heitjan, DF ;

Stevenson, LW ;

Dembitsky, W ;

Long, JW ;

Ascheim, DD ;

Tierney, AR ;

Levitan, RG ;

Watson, JT ;

Meier, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (20) :1435-1443

[4] Medicare reimbursement for destination therapy [J].

Van Nooten, G .

ARTIFICIAL ORGANS, 2004, 28 (06) :526-528

← 1 →